2021 annual financial data
XTL Biopharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -71.56%.
Operating income was -1,031,000 USD and net income was 435,000 USD.
Operating cash flow was -1,049,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,466,000 USD
- Operating income
- -1,031,000 USD
- Net income
- 435,000 USD
- Operating cash flow
- -1,049,000 USD